Stockreport

Lexaria Extends Pharma Partner MTA Through December 31, 2026 as 2026 GLP-1 Data Cycle Approaches [TheStreet.com]

Lexaria Bioscience Corp.  (LEXX) 
PDF It keeps Lexaria's DehydraTECH platform inside an active pharmaceutical evaluation as three GLP-1 readouts approach in the second half of the year. An eight-month exte [Read more]